A detailed history of Aptus Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 27,233 shares of AMGN stock, worth $7.17 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
27,233
Previous 21,718 25.39%
Holding current value
$7.17 Million
Previous $6.79 Million 29.31%
% of portfolio
0.14%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$309.38 - $337.38 $1.71 Million - $1.86 Million
5,515 Added 25.39%
27,233 $8.77 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $1.1 Million - $1.33 Million
4,169 Added 23.76%
21,718 $6.79 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $532,093 - $642,304
-1,979 Reduced 10.13%
17,549 $4.99 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $511 - $576
2 Added 0.01%
19,528 $5.62 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $53,131 - $65,964
-243 Reduced 1.23%
19,526 $5.25 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $3.79 Million - $4.48 Million
17,683 Added 847.7%
19,769 $4.39 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $2.35 Million - $2.86 Million
-10,391 Reduced 83.28%
2,086 $504,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $2.36 Million - $3 Million
10,325 Added 479.79%
12,477 $3.28 Million
Q3 2022

Nov 02, 2022

SELL
$224.46 - $253.15 $6,509 - $7,341
-29 Reduced 1.33%
2,152 $485,000
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $43,834 - $48,780
190 Added 9.54%
2,181 $531,000
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $217,954 - $241,114
994 Added 99.7%
1,991 $481,000
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $1.82 Million - $2.09 Million
-9,163 Reduced 90.19%
997 $224,000
Q3 2021

Oct 27, 2021

SELL
$212.27 - $248.7 $1.46 Million - $1.71 Million
-6,887 Reduced 40.4%
10,160 $2.16 Million
Q2 2021

Jul 27, 2021

BUY
$233.58 - $259.14 $326,778 - $362,536
1,399 Added 8.94%
17,047 $4.16 Million
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $5,547 - $6,465
25 Added 0.16%
15,648 $3.89 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $529,481 - $630,518
2,447 Added 18.57%
15,623 $3.59 Million
Q3 2020

Oct 19, 2020

BUY
$234.65 - $260.95 $102,776 - $114,296
438 Added 3.44%
13,176 $3.35 Million
Q2 2020

Jul 22, 2020

BUY
$197.81 - $242.74 $208,096 - $255,362
1,052 Added 9.0%
12,738 $3 Million
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $259,874 - $344,664
1,426 Added 13.9%
11,686 $2.37 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $447,860 - $575,654
2,367 Added 29.99%
10,260 $2.47 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $94,715 - $113,489
-544 Reduced 6.45%
7,893 $1.53 Million
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $14,336 - $16,805
86 Added 1.03%
8,437 $1.55 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $14,288 - $16,106
79 Added 0.96%
8,351 $1.59 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $1.48 Million - $1.72 Million
8,272 New
8,272 $1.61 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.